Table 2

Change and treatment effect for body composition in men after A) 12 and B) 24 months follow-up

A)

Baseline

Follow-up at 12 months

Change

Treatment effect

d

intervention

control

intervention

control


Number

174

178

166

169

WCa (cm)

99.2 ± 9.5

100.4 ± 9.2

-2.32 ± 3.24**

-1.9 ± 3.06**

-0.48 (-1.16;0.2)

-0.13

BWa (kg)

85.1 ± 11.9

86.1 ± 11.4

-1.86 ± 3.08**

-1.62 ± 3.03**

-0.28 (-0.97;0.42)

-0.08

BMIa (kg/m2)

26.7 ± 3.6

27.3 ± 3.1

-0.49 ± 1.01**

-0.43 ± 0.98**

-0.07 (-0.29;0.15)

-0.06

HCa (cm)

101.9 ± 5.4

102.2 ± 5.3

-1.74 ± 1.70**

-1.53 ± 1.88**

-0.24 (-0.66;0.17)

-0.12

TCa (cm)

56.8 ± 3.6

57.0 ± 3.3

-1.32 ± 1.49**

-1.15 ± 1.76**

-0.17 (-0.55;0.22)

-0.10

SagDa (cm)

21.8 ± 2.7

22.3 ± 3.0

-1.07 ± 1.42**

-1.17 ± 1.77**

-0.01 (-0.33;0.31)

0.06

CCa (cm)

38.8 ± 2.7

39.1 ± 2.3

-0.93 ± 1.08**

-0.85 ± 0.81**

-0.09 (-0.30;0.12)

-0.08

ACa (cm)

32.6 ± 2.6

32.8 ± 2.5

-0.73 ± 1.15**

-0.59 ± 1.01**

-0.15 (-0.38;0.08)

-0.13

SBPa (mmHg)

142.7 ± 16.8

145.6 ± 17.9

-6.50 ± 9.93**

-4.59 ± 12.45

-2.36 (-4.72;0.01)

-0.17

DBPa (mmHg)

86.1 ± 10.1

86.1 ± 8.9

-4.03 ± 6.62**

-2.79 ± 7.23**

-1.25 (-2.66;0.15)

-0.18

TBFa (%)

30.4 ± 4.5

30.6 ± 4.7

-0.26 ± 2.23

-0.31 ± 4.13

0.02 (-0.68;0.72)

0.02

B)

Baseline

Follow-up at 24 months

Change

Treatment effect

intervention

control

intervention

control

Number

174

178

147

154

WCa (cm)

99.2 ± 9.5

100.4 ± 9.2

-1.06 ± 3.48**

-1.08 ± 3.60**

-0.10 (-0.82;0.79)

0.01

BWa (kg)

85.1 ± 11.9

86.1 ± 11.4

-1.47 ± 3.66**

-1.58 ± 3.96*

0.10 (-0.77;0.97)

0.03

BMIa (kg/m2)

26.7 ± 3.6

27.3 ± 3.1

-0.37 ± 1.12**

-0.40 ± 1.29*

0.02 (-0.27;0.30)

0.02

HCa (cm)

101.9 ± 5.4

102.2 ± 5.3

-1.00 ± 1.88**

-0.82 ± 2.29**

-0.18 (-0.69;0.32)

-0.09

TCa (cm)

56.8 ± 3.6

57.0 ± 3.3

-0.77 ± 1.54**

-0.67 ± 2.05**

-0.08 (-0.54;0.36)

-0.06

SagDa (cm)

21.8 ± 2.7

22.3 ± 3.0

-0.52 ± 1.50**

-0.83 ± 2.06**

0.22 (-0.19;0.62)

0.17

CCa (cm)

38.8 ± 2.7

39.1 ± 2.3

-0.43 ± 0.88**

-0.41 ± 0.96**

-0.04 (-0.27;0.20)

-0.02

ACa (cm)

32.6 ± 2.6

32.8 ± 2.5

-0.47 ± 1.22**

-0.42 ± 1.13**

-0.06 (-0.33;0.21)

-0.04

SBPa (mmHg)

142.7 ± 16.8

145.6 ± 17.9

-4.19 ± 12.03**

-4.57 ± 14.68*

-0.29 (-3.24;2.69)

0.03

DBPa (mmHg)

86.1 ± 10.1

86.1 ± 8.9

-2.89 ± 7.86**

-2.54 ± 7.21**

-0.38 (-1.98;1.21)

-0.05

TBFa (%)

30.4 ± 4.5

30.6 ± 4.7

0.08 ± 2.49

-0.26 ± 2.80

0.32 (-0.30;0.94)

0.13


aWC = waist circumference, BW = body weight, BMI = Body Mass Index, HC = hip circumference, TC = thigh circumference, SagD = sagittal diameter, CC = calf circumference. AC = arm circumference, SBP = systolic blood pressure, DBP = diastolic blood pressure, TBF = total body fat. Data are presented as mean ± standard deviation unless stated otherwise. *p < 0.05 and *p < 0.0001 for within-group-changes. Estimates for treatment effect (95% confidence interval) reflect the between-group-difference and are adjusted for baseline measurements and cluster randomisation. Cohen's d. Small: d ≤ 0.33; Medium: 0.33 <d < 0.55; Large: d ≥ 0.56.

Werkman et al. BMC Public Health 2010 10:110   doi:10.1186/1471-2458-10-110

Open Data